We are excited to announce the direct commercialization and launch of Sodium Acetate Injection 2mEq/mL in 20mL, 50mL, and 100mL vials. Sodium Acetate Injection, USP is indicated to prevent or correct hyponatremia.
The direct commercialization of Sodium Acetate allows us to address the shortage for U.S. patients directly. Every day, we continue working on our mission: Making Affordable Medicines Available to All.
Check out the full press release here!
